Dana Pizzuti
Chief Med and Dev Officer · Crinetics Pharmaceuticals, Inc.
- 2024
- Dec 3, 2025
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dana Pizzuti files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeff E. Knight - $3.79M in CRNX purchases and sales in the last 12 months
- Richard Scott Struthers - $822K in CRNX purchases and sales in the last 12 months
- Stephen F. Betz - $397K in CRNX purchases and sales in the last 12 months
- Stephanie Okey - $365K in CRNX purchases and sales in the last 12 months
- Coelho Rogerio Vivaldi - $301K in CRNX purchases and sales in the last 12 months
- Tobin Schilke - $266K in CRNX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dana Pizzuti?
Dana Pizzuti is a corporate insider, tracked as Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc. (CRNX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dana Pizzuti last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 7 filings going back to 2024.
Has Dana Pizzuti been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.70M) across all tracked filings.
